QH BIO PHARMA
00876----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: QH BIO PHARMA(00876) the Revenue is 142.29 M (-15.85%);the EBIT is -15.4 M (-134 times%);the EPS is -0.29 (-656.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.14B15.85%
----
----
EBIT
-0.02B13373.28%
----
----
EPS
-0.2903656.55%
----
----
Upcoming earnings report - Q3 FY2026
Available dateNov 25, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly